NORTHERN TRUST CORP - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 38 filers reported holding TREVI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 9.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$687,912
-10.5%
315,556
-1.9%
0.00%
Q2 2023$768,521
+547.2%
321,557
+401.0%
0.00%
Q1 2023$118,739
+13.7%
64,183
+18.6%
0.00%
Q4 2022$104,442
+71.2%
54,115
+35.5%
0.00%
Q3 2022$61,000
-53.1%
39,927
-13.8%
0.00%
Q2 2022$130,000
+420.0%
46,298
+305.6%
0.00%
Q1 2022$25,000
+177.8%
11,4140.0%0.00%
Q4 2021$9,000
-43.8%
11,4140.0%0.00%
Q3 2021$16,000
-38.5%
11,4140.0%0.00%
Q2 2021$26,000
-16.1%
11,4140.0%0.00%
Q1 2021$31,000
+10.7%
11,4140.0%0.00%
Q4 2020$28,000
-39.1%
11,4140.0%0.00%
Q3 2020$46,000
-56.2%
11,414
-28.7%
0.00%
Q2 2020$105,000
+94.4%
16,002
-2.9%
0.00%
Q1 2020$54,000
-12.9%
16,4800.0%0.00%
Q4 2019$62,000
-16.2%
16,4800.0%0.00%
Q3 2019$74,000
-40.3%
16,4800.0%0.00%
Q2 2019$124,00016,4800.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 11,370,376$24,787,4201.91%
Fairmount Funds Management LLC 5,163,287$11,255,9661.35%
Opaleye Management Inc. 1,705,900$3,718,8621.21%
Frazier Life Sciences Management, L.P. 6,881,090$15,000,7761.00%
VR Adviser, LLC 3,422,397$7,460,8250.78%
SILVERARC CAPITAL MANAGEMENT, LLC 927,415$2,021,7650.61%
Rubric Capital Management LP 5,684,420$12,392,0360.46%
Tejara Capital Ltd 180,227$392,8950.22%
PFS Partners, LLC 100,000$218,0000.19%
WealthTrust Axiom LLC 93,500$203,8300.07%
View complete list of TREVI THERAPEUTICS INC shareholders